Basic Science and Co-entrepreneurship, my Experience

Presenter: Robert Huber

Published: July 2014

Age: 18-22 and upwards

Views: 603 views

Tags: protein;pharma;industry;

Type: Lectures

Source/institution: Lindau-Nobel

The design and development of inhibiting (or occasionally activating) ligands of target proteins in medicine and crop protection guided by molecular structures and functions has become an established technology in academia and industry recently._ Dr Huber presents examples from the protein groups of proteolytic enzymes and antibodies describing research background gathered in academia (http://www.biochem.mpg.de/eg/huber/publications ) and translation into industry, a process which he attended as co-founder and scientific advisor with the companies Proteros (http://www.proteros.de) and Suppremol (http://www.suppremol.com).